(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

JORVEZA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

JORVEZA

ST13

US500000079213908

Class

5

Filing

79213908

Registration

5398764

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

07/12/2025

Trademark type

Word

Nice classes

5

Filing date

06/13/2017

Registration date

02/13/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/07/2025

Last transaction

07/12/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Freiburg, DE

Examiner

THOMAS, JULIE

Current location

Historical data usage

Holders and representatives

Holders

Dr. Falk Pharma GmbH
Dr. Falk Pharma GmbH

Representatives

Eric S. Furman Knobbe Martens Olson & Bear, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of inflammation of the upper gastrointestinal tract

Publications

History of USPTO decisions and trademark events.

34 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/11/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

03/07/2025

71AG

REGISTERED-SEC.71 ACCEPTED

03/07/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/23/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/03/2025

ES71

TEAS SECTION 71 RECEIVED

07/31/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/23/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

02/13/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/24/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/11/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/29/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/18/2018

FIMP

FINAL DISPOSITION PROCESSED

05/18/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/13/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

02/13/2018

GPNX

NOTIFICATION PROCESSED BY IB

12/09/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/28/2017

PUBO

PUBLISHED FOR OPPOSITION

11/28/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/22/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/22/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/08/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/19/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/18/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/17/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/17/2017

RFNT

REFUSAL PROCESSED BY IB

10/07/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/20/2017

RFRR

REFUSAL PROCESSED BY MPU

09/20/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/17/2017

CNRT

NON-FINAL ACTION WRITTEN

09/16/2017

DOCK

ASSIGNED TO EXAMINER

09/12/2017

MAFR

APPLICATION FILING RECEIPT MAILED

08/15/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/11/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/10/2017

Continuous trademark protection

Get notified about every new filing that threatens JORVEZA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.